Po-Shun Lee

Po-Shun Lee has a diverse work experience in the healthcare and pharmaceutical industries. Po-Shun started their career at BioAegis Therapeutics, Inc. as a Founding Scientist and Advisor in 2011. Po-Shun then moved on to Vertex Pharmaceuticals, where they worked as an Associate Medical Director, Clinical Development from 2010 to 2013. After that, they joined Novartis Institutes for BioMedical Research as a Translational Medicine Expert from 2013 to 2014.

In 2014, Po-Shun Lee joined Proteostasis Therapeutics, Inc. as the VP Clinical Development and later became the Chief Medical Officer and EVP from 2015 to 2019. Following this, they worked at Tufts Medical Center as part of the Pulmonary and Critical Care Division in 2015.

In 2019, Po-Shun Lee took on the role of Advisor to the Board at Nephroceuticals and also became the Managing Partner at Puddingstone Spark LLC. Po-Shun continued their journey in the pharmaceutical industry by joining Platelet BioGenesis as the Chief Medical Officer from 2020 to 2021. In the same year, they became a Director of the Board of Directors at Metis Pharmaceuticals Inc.

Currently, Po-Shun Lee is the Chief Medical Officer at Generian, starting in 2021.

Po-Shun Lee has a Bachelor of Arts degree in Biology from The Johns Hopkins University. Additionally, they hold a Medical Doctor (MD) degree from the University of Pennsylvania School of Medicine.